Dynamic force spectroscopy for drug design.

被引：0

作者：

Williams, PM ^{[1
]}

Patel, A ^{[1
]}

Allen, S ^{[1
]}

Roberts, CJ ^{[1
]}

Tendler, SJB ^{[1
]}

Davies, MC ^{[1
]}

机构：

[1] Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

064-COLL

引用

页码：U406 / U406

页数：1

共 50 条

[1] Chirality and drug design.
Anderson, PS
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 285 - MEDI
[2] Issues of solvation in drug design.
Stouch, TR
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U474 - U474
[3] Molecular connectivity and drug design.
Galvez, J
Garcia-Domenech, R
de Julián-Ortiz, JV
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U284 - U284
[4] The latentiation process in drug design.
Chin, CM
Ferreira, EI
[J]. QUIMICA NOVA, 1999, 22 (01): : 75 - 84
[5] The importance of metabolism in drug design.
Pereira, Darcio Gomes
[J]. QUIMICA NOVA, 2007, 30 (01): : 171 - 177
[6] Bioavailability consideration in drug design.
Baldwin, JJ
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U459 - U459
[7] Use of genomic information in drug design.
Caron, P
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U390 - U390
[8] Metalloamindglycosides: An inorganic approach to drug design.
Cowan, JA
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U109 - U109
[9] Integrated approaches for peptidomimetic drug design.
Goodman, M
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : B200 - B201
[10] Computer-aided drug design.
Holloway, MK
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U544 - U544